IMPACTOS DA SÍNDROME METABÓLICA NA ADOLESCÊNCIA E NA PUBERDADE: REVISÃO DA LITERATURA

Autores

  • Danilo Lopes Ribeiro UNEMAT
  • Camille Moreira Baptista da Silva UNEMAT
  • Marcio Garcia Barroso UNEMAT

Resumo

A Síndrome Metabólica (SM) compreende a ocorrência concomitante de fatores de risco para doenças cardiovasculares e para diabetes mellitus tipo 2. Na infância e na adolescência, a síndrome é de difícil diagnóstico, pois os parâmetros e critérios se diferem aos utilizados em adultos e não são bem definidos. Além das divergências na literatura, os parâmetros variam também em decorrência da puberdade, visto que o início da vida adulta representa uma fase de transformações fisiológicas, como regulação hormonal, redistribuição de gordura corporal, mudanças no apetite e alto risco de ganho ponderal, podendo evoluir para obesidade. Este trabalho buscou revisar os estudos feitos até o presente momento acerca da SM, sobretudo na faixa pediátrica, e, de maneira analítica, pontuar critérios diagnósticos, resultados comuns, divergências e possíveis sugestões de estudos futuros que contemplem a complexidade da SM em crianças e adolescentes, bem como seus impactos na puberdade. A metodologia adotada para essa revisão identificou criteriosamente estudos relevantes que abordassem analiticamente a Síndrome Metabólica em faixa pediátrica, sendo consultadas duas bases eletrônicas de dados em saúde, Scientific Electronic Library Online (SciELO) e PubMed, além do acervo digital da Universidade Federal do Paraná (UFPR) e o repositório de manuais da Sociedade Brasileira de Pediatria (SBP). Este estudo analisou os principais fatores capazes de desencadear a SM bem como o seu diagnóstico, que, em geral, considera o conjunto de quatro condições clínicas: obesidade, dislipidemia, hipertensão arterial e resistência à insulina. Ademais, compreendeu-se como a SM impacta o eixo gonadotrófico, podendo ocorrer de modo dessemelhante em indivíduos de sexo diferente. Constatou-se, pois, do desenvolvimento deste trabalho, que as evidências abordadas são clinicamente relevantes e expressam o cenário de conhecimento atual acerca da SM, sobretudo entre crianças e adolescentes.

Biografia do Autor

Danilo Lopes Ribeiro, UNEMAT

Acadêmico do Curso de Medicina da Universidade do Estado de Mato Grosso - UNEMAT

Camille Moreira Baptista da Silva, UNEMAT

Acadêmica do Curso de Medicina da Universidade do Estado de Mato Grosso - UNEMAT

Marcio Garcia Barroso, UNEMAT

Professor Doutor do Curso de Medicina da Universidade do Estado de Mato Grosso - UNEMAT

Referências

Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-1607. doi:10.2337/diab.37.12.1595

Lopes HF. Hipertensão arterial e síndrome metabólica: além da associação. Rev Soc Cardiol Estado São Paulo. 2003;13:64-77.

Moraes ACF de, Fulaz CS, Netto-Oliveira ER, et al. Prevalência de síndrome metabólica em adolescentes: uma revisão sistemática. Cad Saude Publica. 2009;25:1195–1202.

Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of metabolic syndrome phenotype in adolescents. Arch Pediatr Adolesc Med. 2003;157:821-827.

Grundy S, Brewer H, Cleeman J, Smith S, Lenfant C. Definition of metabolic syndrome report of National Heart Lung and Bood Institute / American Heart associacion conference on scientific issues related to definition. Circulation. 2004;109:433-438.

Vitolo MR. Nutrição: Da Gestação Ao Envelhecimento. 2nd ed. Editora Rubio; 2015.

Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetes Med. 1998;15:539-553.

NCEP-ATP III. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(2486-2497).

Alberti KG, Zimmet P, Shaw J. Metabolic syndrome – a new world-wide definition. A consensus statement from the international diabetes federation. Diabetes Med. 2006;23:469-480.

Sewaybricker LE, Antonio MÂRGM, Mendes RT, et al. Metabolic syndrome in obese adolescents: what is enough? Rev Assoc Med Bras. 2013;59(1):64–71.

Reaven GM. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr. 2006;83:1237-1247.

Ford ES, Chaoyang L. Defining the metabolic syndrome in children and adolescents: will the real definition please stand up? J Pediatr. 2008;152:160-164.

Jones KL. The dilemma of the metabolic syndrome in children and adolescents: disease or distraction? Pediatr Diabetes. 2006;7:311-321.

Strufaldi MW, Silva EM, Puccini RF. Metabolic syndrome among prepubertal Brazilian schoolchildren. Diabetes Vasc Dis Res. 2008;5:291-297.

Dhuper S, Cohen HW, Daniel J, Gumidyala P, Agarwalla V, Victor RS. Utility of the modified ATP III defined metabolic syndrome and sever obesity predictors of insulin resistance in overweight children and adolescents: a cross-sectional study. Cardiovasc Diabetol. 2007;6:1-9.

Bouzas I. Síndrome metabólica na adolescência. Adolescência & Saúde. 2011;8(3):54-62. https://cdn.publisher.gn1.link/adolescenciaesaude.com/pdf/v8n3a08.pdf

Matos AFG, Moreira RO, Guedes EP. Aspectos Neuroendócrinos da Síndrome Metabólica. Arq Bras Endocrinol Metab. 2003;47(4):410-421. https://cdn.publisher.gn1.link/adolescenciaesaude.com/pdf/v8n3a08.pdf

Lottenberg SA, Glezer A, Turatti LA. Síndrome metabólica: identificando fatores de risco. J Pediatr (Rio J). 2007;83(5 Suppl):204-208. doi:10.2223/JPED.1715

Kuschnir MCC, Bloch KV, Szklo M, et al. ERICA: Prevalência de síndrome metabólica em adolescentes brasileiros. Rev Saude Publica. 2016;50(supl 1):11s. doi:10.1590/S01518-8787.2016050006701

Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the third National and Nutrition Examination Survey. JAMA. 2002;287:356-359.

Daskalopoulou SS, Mikhailidis DP, Elisaf M. Prevention and treatment of the metabolic syndrome. Angiology. 2004;55:589-612.

Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350(23):2362-2374.

Veugelers PJ, Fitzgerald AL. Prevalence of and risk factors for childhood overweight and obesity. CMAJ. 2005;173:607-613.

Silveira D, Taddei JAAC, Escrivão MAMS, Oliveira FLC, Ancona-Lopez F. Risk factors for overweight among Brazilian adolescents of low-income families: a case-control study. Public Heal Nutr. 2005;9(421-428).

Eisenmann JC. On the use of continuous metabolic syndrome score in pediatric research. Cardiovasc Diabetol. 2008;7:1-6.

Ten S, Maclaren N. Insulin resistance syndrome in children. J Clin Endocrinol Metab. 2004;89:2526-2539.

Olshansky SJ, et al. A potential decline in life expectancy in the United States, 1999-2004. JAMA. 2005;295:1549-1555.

Giuliano I de C, Coutinho MS, Freitas SF, Pires MM, Zunino JN, Ribeiro RQ. Lípides séricos em crianças e adolescentes de Florianópolis, SC: Estudo Floripa Saudável 2040. Arq Bras Cardiol. 2005;85(2):85-91.

Goodman E, Dolan LM, Morrison JA, Daniels SR. Factor analysis of clustered cardiovascular risks in adolescence: obesity is the predominant correlate os risk among youth. Circulation. 2005;111(15):1970-1977.

Srinivasan SR, Myers L, Berenson GS. Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood: the Bogalusa Heart Study. Diabetes. 2002;51(1):204-209.

Steinberger J. Diagnosis of the metabolic syndrome in children. Curr Opin Lipidol. 2003;14:555-559.

Zambon MP, Antonio MARGM, Mendes RT, Barros Filho AA. Características clínicas e laboratoriais de crianças e adolescentes obesos. Rev Paul Pediatr. 2007;25:27-32.

Sociedade Brasileira de Cardiologia. I Diretriz de prevenção da aterosclerose na infância e adolescência. Arq Bras Cardiol. 2005;85(sVI):1-36.

Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics. 1999;103(6 Pt 1):1075-1082.

Rank M, Siegrist M, Wilks DC, et al. The cardio-metabolic risk of moderate and severe obesity in children and adolescents. J Pediatr. 2013;163(1):137-142.

Organização Mundial da Saúde. Obesidade: Prevenindo e Controlando a Epidemia Global: Relatório Da Consultoria Da OMS. Editora Roca; 2004.

Sun SS, Liang R, Huang TT, et al. Childhood obesity predicts adult metabolic syndrome: the fels longitudinal study. J Pediatr. 2008;152:191-200.

Morrison JA, Friedman LA, Wang P, Glueck CJ. Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes 25-30 years later. J Pediatr. 2008;152:201-206.

Brasil, Ministério da Saúde. Síndrome metabólica. Published 2018. Accessed November 18, 2020. http://bvsms.saude.gov.br/dicas-em-saude/2610-sindrome-metabolica

Poyrazoglu S, Bas F, Darendeliler F. Metabolic syndrome in young people. Curr Opin Endocrinol Diabetes Obes. 2014;21(1):56-63.

Weiss R, Bremer AA, Lustig RH. What is metabolic syndrome, and why are children getting it? Ann NY Acad Sci. 2013;1281:123-140.

Bremer AA, Mietus-Snyder M, Lustig RH. Toward a unifying hypothesis of metabolic syndrome. Pediatrics. 2012;129:557–570.

Voulgari C, Tentolouris N, Dilaveris P, et al. Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals. J Am Coll Cardiol. 2011;58:1343–1350.

Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med. 2002;346:802–810.

Zimmet P, Alberti KG, Kaufman F, et al. IDF Consensus Group. Metab Syndr Child Rep Pediatr Diabetes. 2007;8(5):299-306.

Escobar-Morreale HF, San Millán JL. Abdominal adiposity and the polycystic ovary syndrome. Trends Endocrinol Metab. 2007;18(7):266-272.

Mohamed-ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes. 1998;22:1145-1158.

Giogrino F, Laviola L, Eriksson JW. Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies. Acta Physiol Scand. 2005;183:13-30.

Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 2000;21:697-738.

Godoy-Matos AF. Síndrome Metabólica. Atheneu; 2005.

Sociedade Brasileira de Pediatria. Obesidade Na Infância e Adolescência – Manual de Orientação. 3a. Sociedade Brasileira de Pediatria - Departamento Científico de Nutrologia; 2019. https://www.sbp.com.br/fileadmin/user_upload/Manual_de_Obesidade_-_3a_Ed_web_compressed.pdf

Cornier MA, Dabelea D, Hernandez TL. The metabolic syndrome. Endocr Rev. 2008;29:777-822.

Takahashi Y, Fukusato T. Pediatric nonalcoholic fatty liver disease: overview with emphasis on histology. World J Gastroenterol. 2010;16:5280-5285.

Madeira IR, Carvalho CN, Gazolla FM, Matos HJ de, Borges MA, Bordallo MA. Cut-off point for Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) index established from receiver operating characteristic (ROC) curve in the detection of metabolic syndrome in overweight pre-pubertal children. Arq Bras Endocrinol Metab. 2008;52:1466-1473.

Kurto?lu S, Hatipo?lu N, Maz?c?o?lu M, Kendirici M, Keskin M, Kondolot M. Insulin resistance in obese children and adolescents: HOMA-IR cut-off levels in the prepubertal and pubertal periods. J Clin Res Ped Endocrinol. 2010;2:100-106.

Nelson RA, Bremer AA. Insulin resistance and metabolic syndrome in the pediatric population. Metab Syndr Relat Disord. 2010;8:1-14.

International Diabetes Federation. Worldwide definition of the metabolic syndrome. Published 2007. Accessed November 18, 2020. http://www.idf.org

Vermeulen A, Kaufman JM, Deslypere JP, Thomas G. Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men. J Clin Endocrinol Metab. 1993;76(1140-1146).

Haffner SM, Karhapää P, Mykkänen L, Laakso M. Insulin resistance, body fat distribution, and sex hormones in men. Diabetes. 1994;43:212-219.

Zumoff B, Strain GW, Miller LK, et al. Plasma free and non-sex-hormone-bindingglobulin-bound testosterone are decreased in obese men in proportion to their degree of obesity. J Clin Endocrinol Metab. 1990;71:929-931.

Caprio M, Isidori AM, Carta AR, Moretti C, Dufau ML, Fabbri A. Expression of functional leptin receptor in rodent leydig cells. Endocrinology. 1999;140:4939-4947.

Zhang YW, Stern B, Rebar RW. Endocrine comparison of obese menstruating and amenorreic women. J Clin Endocrinol Metab. 1984;58:1077-1084.

Nestler JE. Sex hormone-binding globulin: a marker for hyperinsulinemia and/or insulin resistence (editorial). J Clin Endocrinol Metab. 1993;76:273-274.

Tena-Sempere M, Pinilla L, Gonzalez LC, Diequez C, Casanueva FF, Aguilar E. Leptin inhibits testosterone secretion from adults rats testis in vitro. J Endocrinol. 1999;161:211-218.

Nestler JE, McClanahan MA, Clore JN, Blackard WG. Insulin inhibits adrenal 17,20-lyase activity in men. J Clin Endocrinol Metab. 1992;53:828-831.

Söderberg S, Olsson T, Eliasson M, et al. A strong association between biologically active testosterone and leptin in non-obese men and women is lost with increasing central adiposity. Int J Obes. 2001;25:98-105.

Isidori AM, Caprio M, Strollo F, et al. Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J Clin Endocrinol Metab. 1999;84:3673-3680.

Lima N, Cavaliere H, Halpern A, Medeiros-Neto G. A função gonadal do homem obeso. Arq Bras Endocrinol Metab. 2000;44:31-37.

Cohen PG. Aromatase, adiposity, aging and disease. The hypogonadal-metabolic-atherogenic-disease and aging conection. Med Hypothesis. 2001;56:702-708.

Carr BR. Disorders of the ovaries and female reproductive tract. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, Eds. Williams Textbook of Endocrinology. 9th ed. WB Saunders; 1998:751-818.

Livingstone C, Collison M. Sex steroids and insulin resistence. Clin Sci. 2002;102:151-166.

Ibanez L, Potau N, Zampolli M, et al. Hyperinsulinemia and decreased insulin like growth factor-binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. J Clin Endocrinol Metab. 1997;82:2283-2288.

Ibanez L, Potau N, Zampolli M, et al. Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 1996;81:1237-1243.

Ibanez L, Potau N, Chacon P, et al. Hyperinsulinemia, dyslipidemia and cardiovascular risk in girls with a history of premature pubarche. Diabetologia. 1998;41:1057-1063.

Tfayli H, Arslanian S. Menstrual health and the metabolic syndrome in adolescents. Ann N Y Acad Sci. 2008;1135:85-94.

Hannon TS, Anosky J, Arslanian SA. Longitudinal study of physiologic insulin resistance and metabolic changes of puberty. Pediatr Res. 2006;60(6):759-763.

Moran A, Jacobs JDR, Steinberger J, et al. Insulin Resistance During Puberty. Results From Clamp Studies in 357 Children. Diabetes. 1999;48:2039-2044.

Maclaren NK, Gujral S, Ten S, Motagheti R. Childhood obesity and insulin resistance. Cell Biochem Biophys. 2007;48:73-78.

Fernandez ML. The metabolic syndrome. Nutr Rev. 2007;65(6 Pt 2):S30-34.

Sartia C, Gallagherb J. The metabolic syndrome B Prevalence, CHD risk, and treatment. J Diabetes Its Complicat. 2006;20:121-132.

Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735-2752.

Downloads

Publicado

26/08/2021

Como Citar

Ribeiro, D. L., Baptista da Silva, C. M., & Barroso, M. G. (2021). IMPACTOS DA SÍNDROME METABÓLICA NA ADOLESCÊNCIA E NA PUBERDADE: REVISÃO DA LITERATURA. Revista Ciência E Estudos Acadêmicos De Medicina, 1(14). Recuperado de https://periodicos.unemat.br/index.php/revistamedicina/article/view/5369

Edição

Seção

Artigos

Artigos mais lidos pelo mesmo(s) autor(es)